Con colaboración de @nefrologiaHGM@NefrologiaINC@nefrocmnlr
Cualquier colaboración desde una biopsia es bienvenida.
Por una base de datos de todos para todos en México.
Mayores informes INBOX.
#IMIN2019
Role of complement in the pathophysiology of IgA Nephropathy & Lupus nephritis #KidneyWk#Nephpearls
This figure is from the poster "Phase 2 study evaluating the safety & efficacy of ALNX2050 (Vemircopan), complement Factor D inhibitor in patients w/ IgAN or proliferative LN"
Join us as we discuss the impact of #hyperuricemia on #CKD & #ADPKD patients as well the controversies around treatment modalities. #meded#nephpearls
https://t.co/QczjieSdQJ
BK virus ➡️ Causa importante pérdida del injerto renal 😔
Algoritmo propuesto por los autores muy completo en cuanto al manejo de la Nefropatía por BK 🔝
#nephrology#nephtwitter#MedTwitter#medicine#nephro#Nephpearls
Sawinski et al. CJASN. 2018
https://t.co/xvG8AaWxAT
Started #KidneyWk with #POCUS course and finished by meeting a #POCUS legend. Thanks for the opportunity Dr. Kalagara.
Indeed, interdisciplinary collaboration is the 🔑 for strengthening this field.
#Nephpearls
SGLT2 inhibitors have a role in modifying risk of kidney disease progression & AKI in those w/ type 2 DM at ⬆️ CV risk, and also in those w/ CKD or heart failure “irrespective” of diabetes status, primary kidney disease, or kidney function ca. 2022 #AHA22#KidneyWk#Nephpearls
SGLT2 inhibitors have a role in modifying risk of kidney disease progression & AKI in those w/ type 2 DM at ⬆️ CV risk, and also in those w/ CKD or heart failure “irrespective” of diabetes status, primary kidney disease, or kidney function ca. 2022 #AHA22#KidneyWk#Nephpearls
Comparing the populations of SGLT2 inhibitor trials according to the @goKDIGO classification
📌 CREDENCE
📌 DAPA-CKD
📌 EMPA-KIDNEY: Will include those with low GFR but normal albumin excretion rate
Credit: @P_Rossing#Nephpearls
#POCUS basics:
Spine sign: visualization of the vertebral bodies in the thoracic cavity above the diaphragm – indicative of pleural effusion.
In the absence of pleural effusion, the spine is obscured by air in the lung, and is cut off at the diaphragm.
#Nephpearls#MedEd
EMPA-KIDNEY: Among a wide range of patients w/ CKD who were at risk for disease progression, empagliflozin therapy led to a lower risk of progression of kidney disease or death from CV causes (vs. placebo) ca. 2022 from @NEJM#KidneyWk#AHA22#Nephpearls
https://t.co/PeYaKt4R9m
This study revealed that patients with ANCA Associated Glomerulonephritis with glomerular C3 deposition on IF had worse renal and overall survival rates ca. 2021 from @KIReports#KidneyWk#Nephpearls
👉 https://t.co/RK8CXs4tQJ